Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

RTTNews | 888 dias atrás

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.

RTTNews | 1122 dias atrás

Japan Data On Tap For Friday

Japan is scheduled to release a batch of data on Friday, headlining a busy day for Asia-Pacific economic activity. On tap are July figures for unemployment, industrial production, retail sales, housing starts and construction orders, as well as August data for household confidence and Tokyo inflation.

RTTNews | 47 minutos atrás

Euro Climbs Against Majors

The euro firmed against its major counterparts in the New York session on Thursday.

RTTNews | 1 h 19 min atrás

Swiss Market Ends Marginally Up

The Switzerland market ended marginally up on Thursday after a choppy ride as stocks swung between gains and losses right through the day's trading session.

RTTNews | 4 h 57 min atrás

European Stocks Close Weak

European stocks closed lower on Thursday as the mood remained largely cautious with investors closely following geopolitical news, digesting tech giant Nvidia's earnings, and some crucial economic data from the U.S.

RTTNews | 5 h 17 min atrás

Canadian Stocks Turning In Mixed Performance; TSX Down Marginally

After a positive start and a subsequent drop early on in the session, the Canadian market remains weak around early afternoon on Thursday, weighed down by losses in consumer staples, industrials and communications sectors.

RTTNews | 5 h 50 min atrás

U.S. Pending Home Sales Fall More Than Expected In July

A report released by the National Association of Realtors on Thursday showed pending home sales in the U.S. fell by more than expected in the month of July. NAR said its pending home sales index decreased by 0.4 percent to 71.7 in July after sliding by 0.8 percent to 72.0 in June. Economists had expected pending home sales to edge down by 0.1 percent.

RTTNews | 8 h 17 min atrás

EURUSD	1.1675	GBPUSD	1.35075	AUDUSD	0.65278
USDJPY	146.998	USDCAD	1.37512	USDCHF	0.80187